Epic genetic: the hidden story of wheat

09 August 2018

Published in Genome Research, based on a novel method developed by Earlham Institute, UK, an international research team have uncovered the hidden genetic secrets that give wheat its remarkable ability for local adaptation - revealing a previously untapped resource for breeding better, more resilient wheat.

Globally, wheat, together with maize and rice, provides the most human nutrition. It can thrive in a whole range of different environments, even within a similar geographical region. 

Exploring one hundred different wheat lines worldwide, the research team led by the Earlham Institute in collaboration with Helmholtz Zentrum München, University of Liverpool and the John Innes Centre have revealed a trove of epigenetic variation that was previously unknown to current genotyping methods.

The new findings link crop evolution and phenotypic change to agricultural conditions - allowing us to protect future yields with a climate resistant armour through new breeding methods - contributing to the success of this global crop as well as significant implications for the wheat community. 

With DNA, it’s not always about the sequence of As, Ts, Gs and Cs. Although they contain the vital code that lets us make proteins, there are many other aspects to a genome than just the gene sequences.

One aspect is epigenetics - changes in how genes are expressed. Extra to the DNA sequence, the individual letters might come attached with a ‘methyl group’. Methylation is very important because it means that genes can be turned off, or the way DNA is stored can change, changing the way genetic information is read.

This is important because these changes can happen due to the environment, but are still inherited. This means, in certain conditions, if an epigenetic change happens that is beneficial, this can be passed on to the next generation.

The research team found geographical patterns in these epigenetic changes between the 100 landraces of wheat studied, which suggests that these changes have arisen due to environmental conditions in those local areas.

This is exciting because it means that breeders have a hidden tool up their wheat sleeve. Currently, it’s all about SNPs - single changes in a DNA sequence that have an effect on disease or environmental resistance, for example. Now, even if the DNA sequence is the same, there might be subtle changes at the epigenetic level that we can use to improve how plants respond to local conditions.

Essentially, there are more tools to enable farmers to keep on growing the best possible crop for their local environment.

Group Leader Professor Anthony Hall at the Earlham institute, says: “We are very proud of our groundbreaking piece of fundamental work indicating that DNA methylation offers a broad and stable source of variation for wheat breeders.

“Our next step is to translate this fundamental work on DNA methylation to a technology that is transformative, relevant and accessible to wheat breeders for the development of new cultivars.”

Dr Laura-Jayne Gardiner, Senior Postdoctoral Scientist, added: “What is really neat is, even though we are working with a hugely complex genome which is five times the size of the human genome, we’re able to translate this discovery into a tool for breeders in likely to be just a few years. As a scientist, it's incredibly exciting that your research could have such an immediate impact.” 

Funded by ERA-CAPS, the ERA-Net for Coordinating Action in Plant Sciences, BBSRC, DFG and NSF, this research builds on Earlham Institute’s previous epigenetic work on Chinese Spring wheat (Clavijo et al., Genome Research, 2017) using the advances in wheat genomic resources, as well as in preparation for the International Wheat Genome Sequencing Consortium.  

 

Notes to editors

Images can be found, here. Images show Prof Anthony Hall and Dr Laura-Jayne Gardiner in the wheat field at Earlham Institute.

The published paper “Hidden variation in polyploid wheat drives local adaptation” in Genome Research describes a landmark piece of research of broad interest. We demonstrate that there is massive untapped diversity in the large complex hexaploid genome of bread wheat, in methylation and transposon expansion that is invisible to current genotyping methods. We correlate this with phenotypic change and genome evolution. This has important implications for wheat researchers, breeders, geneticists, plant scientists and biologists.

We demonstrate:

Three main sources of variation across wheat landraces; high transposable element (TE) variability, alongside epigenetic and genetic diversity

Subsets of stable and variable methylation

Local environment drives methylations patterns for adaptation, and we link this to phenotype

Methylation states can become preferentially ‘hard coded’ as SNPs via 5- methylcytosine deamination

Link between methylation, gene expression and salt tolerance

Likely to be a seminal paper in understanding variation in wheat as well as in understanding evolution and genome regulation in polyploids more generally. This opens the door for a whole series of important biological questions about the role of epigenetics in the domestication and adaptation of crops. Not only are these important scientific questions, additionally, we provide evidence for a huge level of untapped variation for crop breeders and the scientific community to exploit. Finally, the underlying data, for which we have already received a large number of requests for access to, will become an important resource for biologists; alongside the release of the raw sequencing data we are currently making the SNPs and methylation sites easily accessible via the Ensembl wheat genome browser.

For more information, please contact:

Hayley London

Marketing & Communications Officer, Earlham Institute (EI)

  • +44 (0)1603 450 107

hayley.london@earlham.ac.uk

The Earlham Institute (EI) is a world-leading research Institute focusing on the development of genomics and computational biology. EI is based within the Norwich Research Park and is one of eight institutes that receive strategic funding from Biotechnology and Biological Science Research Council (BBSRC) - £5.43m in 2017/18 - as well as support from other research funders. - as well as support from other research funders. EI operates a National Capability to promote the application of genomics and bioinformatics to advance bioscience research and innovation.

EI offers a state of the art DNA sequencing facility, unique by its operation of multiple complementary technologies for data generation. The Institute is a UK hub for innovative bioinformatics through research, analysis and interpretation of multiple, complex data sets. It hosts one of the largest computing hardware facilities dedicated to life science research in Europe. It is also actively involved in developing novel platforms to provide access to computational tools and processing capacity for multiple academic and industrial users and promoting applications of computational Bioscience. Additionally, the Institute offers a training programme through courses and workshops, and an outreach programme targeting key stakeholders, and wider public audiences through dialogue and science communication activities.

www.earlham.ac.uk

The Biotechnology and Biological Sciences Research Council (BBSRC) is part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government.

BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.

Funded by government, BBSRC invested £469 million in world-class bioscience in 2016-17. We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.